Robert Galvin, MD

Throughout Dr. Galvin’s career pathway towards pediatric neuro-oncology, he developed a passion for the holistic care of patients and families affected by a brain tumor diagnosis. This encompasses compassionate and thorough high quality clinical care, engagement in research, and community advocacy. His research encompasses identifying new therapeutic opportunities to treat complications of Neurofibromatosis Type 1 and investigation of immunologic vulnerabilities of a subtype of glioblastoma, a malignant brain cancer, that affects children and young adults called diffuse hemispheric glioma, H3 G34-mutant. As a member of the Brain Tumor Program at the University of Minnesota, he strives to ensure availability of treatment options and clinical trial opportunities for those in need while working with the brain tumor community to continue making discoveries and advancements that will improve the lives of individuals affected by a brain tumor diagnosis.